Orlando, A., Armuzzi, A., Papi, C., Annese, V., Ardizzone, S., Biancone, L., et al. (2011). The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆. DIGESTIVE AND LIVER DISEASE, 43(1), 1-20 [10.1016/j.dld.2010.07.010].

The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆

BIANCONE, LIVIA;
2011-01-01

2011
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/12 - GASTROENTEROLOGIA
English
Orlando, A., Armuzzi, A., Papi, C., Annese, V., Ardizzone, S., Biancone, L., et al. (2011). The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆. DIGESTIVE AND LIVER DISEASE, 43(1), 1-20 [10.1016/j.dld.2010.07.010].
Orlando, A; Armuzzi, A; Papi, C; Annese, V; Ardizzone, S; Biancone, L; Bortoli, A; Castiglione, F; D’Incà, R; Gionchetti, P
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/101283
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 127
  • ???jsp.display-item.citation.isi??? 111
social impact